Protocol Validation of Dynamometric Measurement of Passive Inter-segmental Stiffness and Spasticity in Children With Cerebral Palsy
Launched by FONDATION ELLEN POIDATZ · Oct 20, 2020
Trial Information
Current as of September 25, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new way to measure stiffness and spasticity in children with cerebral palsy (CP). Stiffness and spasticity can make it difficult for these children to move, and understanding these issues better can help doctors choose the best treatments. The researchers want to use special tools called dynamometers to take precise measurements of how stiff the joints are in CP children during movement, making the evaluation more accurate than current methods.
To participate in this study, children must be between 7 and 18 years old, have a diagnosis of cerebral palsy, and be able to follow simple instructions. Healthy children in the same age range can also join. Participants will not face any medical procedures or treatments during the trial; instead, they will help researchers test and improve measurement techniques. This study aims to create a reliable method for assessing movement difficulties in children with CP, which could ultimately lead to better treatment options. Parents must give their consent for their child to participate.
Gender
ALL
Eligibility criteria
- The inclusion criteria for PC children are :
- • A clinical diagnosis of CP noted in the medical record
- • An age between 7 and 18 years old
- • Levels I to III for the Global Motor Function Classification System (GMFCS)
- • Ability to cooperate, understand and follow simple instructions
- • Patient affiliated to the French social security system
- • Voluntary patient whose parents have given their consent to participate
- The inclusion criteria for healthy children are :
- • An age between 7 and 18 years old
- • Ability to cooperate, understand and follow simple instructions
- • Patient affiliated to the French social security system
- • Voluntary patient whose parents have given their consent to participate
- Exclusion Criteria:
- • Medical decision for any reason
- • Child or parent decision for any reason
- • Inability to cooperate, to understand and to follow instructions
- • Surgery or botulinum toxin injection within 6 months prior to the start of the study.
- • A diagnosis of a form of dystonia.
About Fondation Ellen Poidatz
Fondation Ellen Poidatz is a dedicated clinical trial sponsor committed to advancing medical research and improving patient outcomes through innovative studies. With a focus on fostering collaboration between researchers, healthcare professionals, and patient communities, the foundation supports a range of clinical trials aimed at addressing unmet medical needs. By prioritizing ethical standards and robust scientific methodologies, Fondation Ellen Poidatz strives to contribute valuable insights to the medical field, ultimately enhancing treatment options and quality of care for patients worldwide.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Saint Fargeau Ponthierry, France
Patients applied
Trial Officials
Eric Desailly, PhD
Principal Investigator
Fondation Ellen Poidatz
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials